Exploring the druggable space around the Fanconi anemia pathway using machine learning and mechanistic models.

The use of artificial intelligence methods for the prediction of potentially causal relationships between proteins of interest and cell activities related with disease-related phenotypes opens promising avenues for the systematic search of new targets in rare diseases.